UNSPSC 51293613: Iprindole hydrochloride

This classification denotes a tricyclic antidepressant C19H28N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z023VDR216, chemically known as 6,7,8,9,10,11-hexahydro-n,n-dimethyl-5h-cyclooct)(b)indole-5-propanamine, hydrochloride, but more generally known as iprindole hydrochloride, which bears US NIH Compound Identifier 159889. European Medicines Agency schedules Iprindole hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02768MIG.

Most nations, for tariff and trade purposes, schedule iprindole hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, IPRINDOLE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN(C)CCCN1C2CCCCC2C3C1CCCCCC3.CL.

UNSPSC 51293613 Iprindole hydrochloride (Commodity) does not align with recent state and local procurement activity under this code. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026, with response deadline July 26, 2023—solicits naloxone and drug deactivation systems for community health initiatives, a pharmaceutical product unrelated to iprindole hydrochloride, an antidepressant medication. The mismatch suggests either a tagging error in the underlying opportunity record or that this Commodity code sees minimal relevant recent activity in state and local procurement.

No representative state and local solicitations for iprindole hydrochloride or closely related pharmaceutical products appear in recent postings. The code warrants monitoring for future activity, but current data does not support a pursue decision based on demonstrated buying patterns.